Conditioning of Langerhans cells induced by a primary CD8 T cell response to self-antigen in vivo

Journal of Immunology

Volumn 176, Issue 8, 2006, Pages 4658-4665

  Mayerova, Dita ^a,b   Wang, Liangchun ^a   Bursch, Laura S ^a   Hogquist, Kristin A ^a,c  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b JOSLIN DIABETES CENTER   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN SPECIFICITY; ARTICLE; AUTOIMMUNE DISEASE; BONE MARROW; CD8+ T LYMPHOCYTE; CHIMERA; CONTROLLED STUDY; DENDRITIC CELL; INFLAMMATION; LANGERHANS CELL; LYMPHOCYTE DEPLETION; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE;

EID: 33645762289     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.176.8.4658     Document Type: Article

References (46)

1. Moser, M. 2003. Dendritic cells in immunity and tolerance - do they display opposite functions? Immunity 19: 5-8.
2. + T cells induce maturation of dendritic cells. J. Mol. Med. 80: 533-541.
3. Ronchese, F., and I. F. Hermans. 2001. Killing of dendritic cells: a life cut short or a purposeful death? J. Exp. Med. 194: F23-26.
4. + T cells mediate CD40-independent maturation of dendritic cells in vivo. J. Exp. Med. 189: 1875-1884.
5. + T cells in the development of T helper type 1 responses. J. Exp. Med. 195: 473-483.
6. Grohmann, U., C. Orabona, F. Fallarino, C. Vacca, F. Calcinaro, A. Falorni, P. Candeloro, M. L. Belladonna, R. Bianchi, M. C. Fioretti, and P. Puccetti. 2002. CTLA-4-Ig regulates tryptophan catabolism in vivo. Nat. Immunol. 3: 1097-1101.
7. McGargill, M. A., D. Mayerova, H. E. Stefanski, B. Koehn, E. A. Parke, S. C. Jameson, A. Panoskaltsis-Mortari, and K. A. Hogquist. 2002. A spontaneous CD8 T cell-dependent autoimmune disease to an antigen expressed under the human keratin 14 promoter. J. Immunol. 169: 2141-2147.
8. Mayerova, D., E. A. Parke, L. S. Bursch, O. A. Odumade, and K. A. Hogquist. 2004. Langerhans cells activate naive self-antigen-specific CD8 T cells in the steady state. Immunity 21: 391-400.
9. + T cells pass through an effector phase during the process of in vivo tolerance induction. J. Immunol. 170: 3945-3953.
10. Hogquist, K. A., S. C. Jameson, W. R. Heath, J. L. Howard, M. J. Bevan, and F. R. Carbone. 1994. T cell receptor antagonist peptides induce positive selection. Cell 76: 17-27.
11. + T cells in vivo. J. Immunol. 166: 6602-6607.
12. Sha, W. C., C. A. Nelson, R. D. Newberry, D. M. Kranz, J. H. Russell, and D. Y. Loh. 1988. Positive and negative selection of an antigen receptor on T cells in transgenic mice. Nature 336: 73-76.
13. Udaka, K., K. H. Wiesmuller, S. Kienle, G. Jung, and P. Walden. 1996. Self-MHC-restricted peptides recognized by an alloreactive T lymphocyte clone. J. Immunol. 157: 670-678.
14. Prlic, M., B. R. Blazar, A. Khoruts, T. Zell, and S. C. Jameson. 2001. Homeostatic expansion occurs independently of costimulatory signals. J. Immunol. 167: 5664-5668.
15. Kieper, W. C., and S. C. Jameson. 1999. Homeostatic expansion and phenotypic conversion of naive T cells in response to self peptide/MHC ligands. Proc. Natl. Acad. Sci. USA 96: 13306-13311.
16. Kieper, W. C., M. Prlic, C. S. Schmidt, M. F. Mescher, and S. C. Jameson. 2001. II-12 enhances CD8 T cell homeostatic expansion. J. Immunol. 166: 5515-5521.
17. Curtsinger, J. M., D. C. Lins, and M. F. Mescher. 2003. Signal 3 determines tolerance versus full activation of naive CD8 T cells: dissociating proliferation and development of effector function. J. Exp. Med. 197: 1141-1151.
18. Vremec, D., M. Zorbas, R. Scollay, D. J. Saunders, C. F. Ardavin, L. Wu, and K. Shortman. 1992. The surface phenotype of dendritic cells purified from mouse thymus and spleen: investigation of the CD8 expression by a subpopulation of dendritic cells. J. Exp. Med. 176: 47-58.
19. Stoitzner, P., S. Holzmann, A. D. McLellan, L. Ivarsson, H. Stossel, M. Kapp, U. Kammerer, P. Douillard, E. Kampgen, F. Koch, et al. 2003. Visualization and characterization of migratory Langerhans cells in murine skin and lymph nodes by antibodies against Langerin/CD207. J. Invest. Dermatol. 120: 266-274.
20. Loyer, V., P. Fontaine, S. Pion, F. Hetu, D. C. Roy, and C. Perreault. 1999. The in vivo fate of APCs displaying minor H antigen and/or MHC differences is regulated by CTLs specific for immunodominant class I-associated epitopes. J. Immunol. 163: 6462-6467.
21. + T cells in vivo: implications for adaptive immunotherapy. Eur. J. Immunol. 31: 1772-1779.
22. + T cell-dependent elimination of dendritic cells in vivo limits the induction of antitumor immunity. J. Immunol. 164: 3095-3101.
23. Huang, J. F., Y. Yang, H. Sepulveda, W. Shi, I. Hwang, P. A. Peterson, M. R. Jackson, J. Sprent, and Z. Cai. 1999. TCR-mediated internalization of peptide-MHC complexes acquired by T cells. Science 286: 952-954.
24. Hudrisier, D., J. Riond, H. Mazarguil, J. E. Gairin, and E. Joly. 2001. Cutting edge: CTLs rapidly capture membrane fragments from target cells in a TCR signaling-dependent manner. J. Immunol. 166: 3645-3649.
25. Hwang, I., J. F. Huang, H. Kishimoto, A. Brunmark, P. A. Peterson, M. R. Jackson, C. D. Surh, Z. Cai, and J. Sprent. 2000. T cells can use either T cell receptor or CD28 receptors to absorb and internalize cell surface molecules derived from antigen-presenting cells. J. Exp. Med. 191: 1137-1148.
26. Sabzevari, H., J. Kantor, A. Jaigirdar, Y. Tagaya, M. Naramura, J. Hodge, J. Bernon, and J. Schlom. 2001. Acquisition of CD80 (B7-1) by T cells. J. Immunol. 166: 2505-2513.
27. + T cells involving acquired MHC class II: peptide complexes: another mechanism to limit clonal expansion? Blood 101: 2704-2710.
28. Kedl, R. M., B. C. Schaefer, J. W. Kappler, and P. Marrack. 2002. T cells down-modulate peptide-MHC complexes on APCs in vivo. Nat. Immunol. 3: 27-32.
29. Probst, H. C., T. Dumrese, and M. F. van den Broek. 2002. Cutting edge: competition for APC by CTLs of different specificities is not functionally important during induction of antiviral responses. J. Immunol. 168: 5387-5391.
30. + T cell effector population size. J. Immunol. 173: 2923-2927.
31. Mueller, S. N., C. M. Jones, C. M. Smith, W. R. Heath, and F. R. Carbone. 2002. Rapid cytotoxic T lymphocyte activation occurs in the draining lymph nodes after cutaneous herpes simplex virus infection as a result of early antigen presentation and not the presence of virus. J. Exp. Med. 195: 651-656.
32. Steinman, R. M., D. Hawiger, and M. C. Nussenzweig. 2003. Tolerogenic dendritic cells. Annu. Rev. Immunol. 21: 685-711.
33. Wilson, N. S., D. El-Sukkari, G. T. Belz, C. M. Smith, R. J. Steptoe, W. R. Heath, K. Shortman, and J. A. Villadangos. 2003. Most lymphoid organ dendritic cell types are phenotypically and functionally immature. Blood 102: 2187-2194.
34. + T-cell receptor transgenic T cells in keratin 14-ovalbumin transgenic mice. J. Invest. Dermatol. 123: 109-115.
35. Geissmann, F., M. C. Dieu-Nosjean, C. Dezutter, J. Valladeau, S. Kayal, M. Leborgne, N. Brousse, S. Saeland, and J. Davoust. 2002. Accumulation of immature Langerhans cells in human lymph nodes draining chronically inflamed skin. J. Exp. Med. 196: 417-430.
36. Loser, K., A. Mehling, J. Apelt, S. Stander, P. G. Andres, H. C. Reinecker, B. R. Eing, B. V. Skryabin, G. Varga, T. Schwarz, and S. Beissert. 2004. Enhanced contact hypersensitivity and antiviral immune responses in vivo by keratinocyte-targeted overexpression of IL-15. Eur. J. Immunol. 34: 2022-2031.
37. Simpson, C. C., G. M. Woods, and H. K. Muller. 2003. Impaired CD40-signalling in Langerhans' cells from murine neonatal draining lymph nodes: implications for neonatally induced cutaneous tolerance. Clin. Exp. Immunol. 132: 201-208.
38. Merad, M., M. G. Manz, H. Karsunky, A. Wagers, W. Peters, I. Charo, I. L. Weissman, J. G. Cyster, and E. G. Engleman. 2002. Langerhans cells renew in the skin throughout life under steady-state conditions. Nat. Immunol. 3: 1135-1141.
39. Mayerova, D., and K. A. Hogquist. 2004. Central tolerance to self-antigen expressed by cortical epithelial cells. J. Immunol. 172: 851-856.
40. Wong, P., and E. G. Pamer. 2003. Feedback regulation of pathogen-specific T cell priming. Immunity 18: 499-511.
41. Groux, H., N. Fournier, and F. Cottrez. 2004. Role of dendritic cells in the generation of regulatory T cells. Semin. Immunol. 16: 99-106.
42. Homann, D., A. Jahreis, T. Wolfe, A. Hughes, B. Coon, M. J. van Stipdonk, K. R. Prilliman, S. P. Schoenberger, and M. G. von Herrath. 2002. CD40L blockade prevents autoimmune diabetes by induction of bitypic NK/DC regulatory cells. Immunity 16: 403-415.
43. Koenen, H. J., and I. Joosten. 2000. Blockade of CD86 and CD40 induces alloantigen-specific immunoregulatory T cells that remain anergic even after reversal of hyporesponsiveness. Blood 95: 3153-3161.
44. Hayday, A., and R. Tigelaar. 2003. Immunoregulation in the tissues by γδ cells. Nat. Rev. Immunol. 3: 233-242.
45. Girardi, M., D. E. Oppenheim, C. R. Steele, J. M. Lewis, E. Glusac, R. Filler, P. Hobby, B. Sutton, R. E. Tigelaar, and A. C. Hayday. 2001. Regulation of cutaneous malignancy by γδ cells. Science 294: 605-609.
46. Jameson, J., K. Ugarte, N. Chen, P. Yachi, E. Fuchs, R. Boismenu, and W. L. Havran. 2002. A role for skin γδ cells in wound repair. Science 296: 747-749.